SG Americas Securities’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,321
| Closed | -$2.4M | – | 3055 |
|
|
2023
Q1 | $2.4M | Buy |
22,321
+10,214
| +84% | +$1.1M | 0.03% | 511 |
|
|
2022
Q4 | $1.33M | Buy |
12,107
+5,544
| +84% | +$610K | 0.02% | 676 |
|
|
2022
Q3 | $387K | Buy |
+6,563
| New | +$387K | ﹤0.01% | 1570 |
|
|
2022
Q1 | – | Sell |
-7,659
| Closed | -$303K | – | 3108 |
|
|
2021
Q4 | $303K | Buy |
7,659
+1,263
| +20% | +$50K | ﹤0.01% | 2205 |
|
|
2021
Q3 | $152K | Buy |
+6,396
| New | +$152K | ﹤0.01% | 3161 |
|